Arbor Pharmaceuticals, a specialty pharmaceutical company, announces the availability of Triptodur (triptorelin), an FDA-approved, twice-yearly injectable gonadotropin-releasing hormone agonist (GnRHa) for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP). Arbor Pharmaceuticals confirms an ample supply with additional product on order.
Arbor Pharmaceuticals, LLC